United Therapeutics Corporation (UTHR)

Fixed asset turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	2,268,200	2,147,800	2,060,800	1,939,800	1,903,900	1,743,300	1,676,600	1,657,700	1,666,900	1,751,900	1,687,000	1,601,600	1,491,500	1,399,000	1,425,300	1,442,500	1,448,800	1,519,100	1,530,300	1,601,200
Property, plant and equipment	US$ in thousands	1,045,400	992,200	938,900	896,500	861,500	840,800	791,400	784,400	780,900	726,700	715,700	713,700	731,600	736,400	744,200	739,200	738,500	678,300	709,300	701,200
Fixed asset turnover		2.17	2.16	2.19	2.16	2.21	2.07	2.12	2.11	2.13	2.41	2.36	2.24	2.04	1.90	1.92	1.95	1.96	2.24	2.16	2.28

December 31, 2023 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $2,268,200K ÷ $1,045,400K
= 2.17

United Therapeutics Corp's fixed asset turnover has been relatively stable over the past eight quarters, ranging from 2.21 to 2.26. This indicates that the company generates approximately $2.21 to $2.26 in revenue for every dollar invested in fixed assets. The consistent performance suggests effective utilization of fixed assets to generate sales revenue. A high fixed asset turnover ratio generally signifies efficient asset management. However, it would be beneficial to compare this ratio with industry peers or historical performance to gain further insights into the company's operational efficiency and asset utilization.